Varian Medical Systems has made a new investment in Bend It Technologies, an Israel-based company that is developing steerable microcatheters.
Bend It’s microcatheters are used by interventionalists for minimally invasive peripheral vascular procedures.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Varian is investing in Bend It’s Series B funding round and a representative of the company will join the latter’s board of directors.
As compared with open surgery, interventional procedures require the injection of diagnostic or therapeutic materials into a targeted area of the body through blood vessels. The microcatheters can be used for delivering diagnostic, embolic or therapeutical materials into the vasculature.
Varian Interventional Solutions business president Francis Facchini said: “The Bend It catheters’ unique design brings 3D steerability to a new dimension in microcatheter technologies, providing interventional radiologists with control of the catheter tip and tip shape to successfully navigate even the most tortuous anatomy.
“This optimises ‘guidewire-less’ navigation for delivery of embolic therapies.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“We believe the Bend It steerable microcatheter has the potential to enhance patient safety, reduce procedure time and produce better outcomes.”
Bend It’s patented technology is FDA 510(k) cleared and CE marked. It offers 3D-controlled bending and navigation capabilities that help doctors provide rapid and precise treatment by placing catheters through blood vessels that are otherwise difficult to traverse.
Furthermore, the Bend It peripheral use microcatheter allows doctors to navigate into the body through the radial artery in the wrist, as well as the more traditional femoral artery in the groin, which can lower patient risk for some procedures.
Bend It CEO Yossi Mazel said: “We are thrilled to have Varian invest in Bend It Technologies and join its board of directors.
“There is no doubt that Varian’s strong market presence will impact Bend It significantly as the company grows its product portfolio and gets ready to commercially launch its steerable catheters.”
